Flector by IBSA is a nonsteroidal anti-inflammatory drug that treats pain and inflammatory diseases. IBSA Group is a multinational pharmaceutical Company with headquarters in Lugano, Switzerland. The production facilities and R&D labs are distributed in Switzerland, Italy and China. IBSA operates in more than 90 countries and 5 continents with 16 subsidiaries in Europe, China and the USA, and employs around 2,000 people distributed among our headquarters, subsidiaries and manufacturing plants.

IBSA holds 90 patent families and many others in development, with a diversified portfolio covering 10 different therapeutic areas. It is one of the four largest operators worldwide in the area of Reproductive Medicine and one of the world’s leaders in hyaluronic acid-based products.

The brand vision of IBSA consists in an approach that goes beyond the drug and beyond the disease, called New Humanism of Care. made possible by the merge of technologies, science and culture. A patient-centred approach that enhances the Person and its care, aiming at the humanisation of care, have a complete attention to the patient, to respond in a concrete way to the needs and requirements of the individual, to enhance the person beyond the disease. Taking care is based on the ability to prevent pathologies, as well as on the ability to enhance the effectiveness of therapies, also through stimulating the creativity as an individual and group resource.